Add BrightSurf on Google Email

Can EP4 agonist alleviate gastric lesions?

A research team investigated a highly-selective EP4 agonist for treatment of gastric ulcers in mice. The EP4 agonist reduced acute hemorrhagic damage, promoted mucous epithelial regeneration, and accelerated ulcer healing. In vitro, it protected human gastric mucous cells from indomethacin-induced apoptosis.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateNov 18, 2009

Gastroenterology/hepatology societies release report evaluating fellowship training curriculum

A new report from gastroenterology/hepatology societies emphasizes the importance of competency-based curriculum and disease-specific training in improving patient outcomes. The report recommends changes to GI training programs, including pairing of GI/hepatology training and enhanced training in specific disease areas.

SourceAmerican Gastroenterological Association·JournalGASTROENTEROLOGY·DateNov 4, 2009

Travel of a mis-swallowed long spoon to the jejunum

A 33-year-old woman accidentally swallowed a 15 cm long spoon while attempting to remove a fish bone from her pharynx. The spoon was found in the lower mid-abdomen on an urgent plain abdominal radiograph and successfully removed during exploratory laparotomy, revealing it had passed into the jejunum after 200 cm of the ligament of Treitz.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

A new explanation of 'Asian paradox'

Researchers investigated gastric mucosal changes prior to gastric cancer in Indonesian and Japanese patients with H. pylori infection. They found significant differences in the grade and activity of mucosal changes, suggesting a different host response between the two populations.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

Is short-term Celecoxib intervention a effective method for preventing gastric carcinogenesis?

A new study found that short-term Celecoxib intervention can effectively prevent gastric carcinogenesis in Mongolian gerbils. The research team suggests that COX-2 inhibitors may be used as chemoprevention for people older than 40 years old, especially those with refractory H. pylori infections at high risk of gastric cancer.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 28, 2009

Long-term treatment with proton pump inhibitor can increase weight

A study published in World Journal of Gastroenterology found that long-term proton pump inhibitor (PPI) treatment can lead to weight gain in patients with gastroesophageal reflux disease (GERD). The research highlights the importance of lifestyle modifications, such as dietary changes and weight management, to mitigate this effect. By ...

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 22, 2009

Which is promising as therapeutic targets in patients with biliary tract cancer? EGFR or HER2?

A study of 124 patients with advanced biliary tract cancer found EGFR overexpression in 39.3% of tumors, while HER2 overexpression and gene amplification were present in only 5% of cases. This suggests that targeting EGFR may be a promising therapeutic approach for BTC, while routine testing and targeting of HER2 is not recommended.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateOct 16, 2009

What are the risk factors for rebleeding after negative angiography?

A study published in the World Journal of Gastroenterology found that underlying malignancy, liver cirrhosis, and hematemesis are key predictors of rebleeding after negative angiographic findings. The research team analyzed 128 patients with acute non-variceal gastrointestinal bleeding who had negative initial angiography results.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateSep 16, 2009

GERD negatively impacts sleep quality, results in considerable economic burden

Researchers found that acid refluxing at night results in sleep arousal 89 percent of the time in participants with and without GERD. GERD patients experience longer acid reflux events, leading to increased risk for complicated disease and esophageal cancer. This association suggests a bi-directional link between sleep problems and GERD.

SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateSep 1, 2009

What is alternative treatment for irritable bowel syndrome when conventional therapy has failed?

A randomized controlled trial found that low-dose imipramine improved global symptoms and quality of life in patients with IBS who had failed conventional therapy. The study, published in the World Journal of Gastroenterology, is the largest ever conducted on the use of tricyclic antidepressants (TCAs) in IBS patients.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateAug 11, 2009

Fecal incontinence and quality of life

A study published in the World Journal of Gastroenterology found that fecal incontinence significantly impacts patients' quality of life, affecting lifestyle, coping behavior, depression, and embarrassment. The results show that over 22% of patients experience severe QOL effects due to FI.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJul 21, 2009

Is molecular adsorbent recirculating system effective for all the liver failure patients?

The study found that molecular adsorbent recirculating system (MARS) treatment is effective in patients with acute liver failure. The etiology of liver failure and the grade of encephalopathy before MARS treatment were significant prognostic factors, while coagulation factor 5 levels were also predictive for unknown etiologies.

SourceWorld Journal of Gastroenterology·JournalWorld Journal of Gastroenterology·DateJul 7, 2009